Morphic Therapeutic (MORF) PT Raised to 'Street High' $111 at BMO Capital
Tweet Send to a Friend
BMO Capital analyst Do Kim raised the price target on Morphic Therapeutic (NASDAQ: MORF) to a "Street High" $111.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
